Invitrogen™ Human ERRF Synthetic Peptide

Ref.: BL-RE-176806Manufacturer ref.: PEP-1577 50 μg
€149.00 excl. VAT

ERRF2 Synthetic Peptide, PEP-1577, from Invitrogen.

Gene ID (Enter)
149563
Species
Human
Purification method
Purified
Accession number
Q8NEQ6
Common name
Human ERRF
Brand
Invitrogen

ERRF2 Synthetic Peptide, PEP-1577, from Invitrogen.

ERRF2 Synthetic Peptide, PEP-1577, from Invitrogen.

The estrogen receptor-related factor (ERRF) is a recently identified protein whose expression is upregulated in multiple cell lines and primary breast cancer tumors. Increased ERRF expression was significantly associated with ER or progesterone receptor (PR) positivity even in HER2-negative tumors. This higher ERRF expression correlated with better disease-free survival and overall survival. In two ER-positive breast cancer cell lines, knockdown of ERRF suppressed cell growth in vitro and tumorigenesis in xenograft models, suggesting that ERRF plays a role in estrogen-ER-mediated breast cancer cell growth and may thus be a potential therapeutic target.

Species

Species: Human.

Conservation

Storage: -20°C.

Formulation

Concentration: 200 μg/mL.

Regulatory status

Research only (RUO).

Packaging

Packaging: 50 μg.

Technical specifications

General
BrandInvitrogen
Supplier ref. (Fisher Scientific)15205509
Specifications
Gene ID (Enter)149563
SpeciesHuman
Purification methodPurified
Accession numberQ8NEQ6
Common nameHuman ERRF
Concentration200 μg/mL
DescriptionSynthetic Peptide
FormatLiquid
FormulaPBS with 0.1% BSA and 0.02% sodium azide; pH 7.2
For use with (application)Blocking Assay, Control
Gene symbol(s)SRARP
LyophilizedNo
Product typePeptide
Quantity50 μg
Regulatory statusRUO - research use only
Storage and shipping
Content and storage-20°C
Conservative0.02% sodium azide
Storage stampPBS

Origin and customs

Manufacturer ref.PEP-1577
Country of originUnited States
HS customs code3824 99 92 00
A question or a specific configuration?
Contact us for a quote.